about
Adenosine A(2) receptors modulate tubuloglomerular feedbackAdenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout micePharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cellsPharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell lineAdenosine stimulates depolarization and rise in cytoplasmic [Ca2+] in type I cells of rat carotid bodiesThe role of adenosine A2A and A3 receptors on the differential modulation of norepinephrine and neuropeptide Y release from peripheral sympathetic nerve terminalsNeuroactive substances specifically modulate rhythmic body contractions in the nerveless metazoon Tethya wilhelma (Demospongiae, Porifera).Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation.Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomesAdenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activityAdenosine: an activity-dependent axonal signal regulating MAP kinase and proliferation in developing Schwann cells.Adenosine A2A receptor activation attenuates tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase.Recent improvements in the development of A(2B) adenosine receptor agonists.Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?A1 and A2A adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells.Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice.CGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activitiesPharmacological characterisation of the adenosine receptor mediating increased ion transport in the mouse isolated trachea and the effect of allergen challengeIdentification and function of adenosine A3 receptor in afferent arterioles.Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.Possible therapeutic benefits of adenosine-potentiating drugs in reducing age-related degenerative disease in dogs and cats.Adenosine negatively regulates duodenal motility in mice: role of A(1) and A(2A) receptors.Adenosine receptor agonists: from basic medicinal chemistry to clinical development.β-Nicotinamide adenine dinucleotide acts at prejunctional adenosine A1 receptors to suppress inhibitory musculomotor neurotransmission in guinea pig colon and human jejunum.The impact of commercially available purinergic ligands on purinergic signalling research.Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cellsExtracellular Adenosine Protects against Streptococcus pneumoniae Lung Infection by Regulating Pulmonary Neutrophil RecruitmentSeason primes the brain in an arctic hibernator to facilitate entrance into torpor mediated by adenosine A(1) receptors.A1 adenosine receptors mediate hypoxia-induced ventriculomegalyPhrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesisIn vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.IB-MECA and cardioprotection.Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonistsRegio- and stereoselective synthesis of truncated 3'-aminocarbanucleosides and their binding affinity at the A3 adenosine receptor.Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptorsInternalization and desensitization of adenosine receptors.Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells.
P2860
Q28284099-BB31CEC2-E50C-433F-BA21-B10B5B7E2D79Q28346715-21C1B283-E48E-4224-92CE-C10F49332D34Q28346743-C5EF783C-2CA1-4335-BEBD-9B3EA60FE3ACQ28363730-76F5F501-C4E7-4DBD-A403-6AA30F03D239Q28572447-BD4D0B6F-4A4B-439A-B3C6-82050CD496D2Q28582835-07855658-B239-4ABD-A670-4036DA91631EQ30477581-691D2091-0F9E-4A21-8D91-17E47C1E3055Q33554208-26AD117B-00C1-4A69-971D-5229863A7CC5Q33730081-560B04D2-1ECA-4F6A-88A6-97340BF7628FQ34074914-0DC55249-5705-46C3-BAC5-F598B2E4C176Q34101256-8C45403E-311C-4029-8C2C-56EA044C1BEFQ34249267-12AA0121-29C2-4A3A-B685-3F595DF8BD88Q34599952-07A84E30-EFA9-48A6-BEE0-D2B271737213Q34774668-631CCF23-AAC1-472D-89A7-BB060F43783FQ34777954-0B431835-07D2-4D2A-A744-84C6E5FF54C3Q35046054-8FBD7169-4151-4ED9-BBD7-C8DFA5C04F5EQ35046240-EE4D67C7-920E-4BBF-A423-58012B308FB6Q35048762-9CC2C698-CF1C-49F9-8291-D1BBFE674FCAQ35048766-04289DA6-E08B-4105-9EA8-299FDD204406Q35573278-A20586B8-581E-4524-A41D-BD7AE500EC9BQ35575133-D534D6A0-B23F-49B2-A6FC-1E6C34A22B2BQ35591292-97372F0D-B066-4EFB-BD74-C3DCA311AFE6Q35593047-FC26EBCB-F0E5-4108-B18F-39E2BE93F5D9Q35602688-BC5B325F-483B-41A6-810B-041813A82084Q35671813-9917ADAD-D3D7-43F9-99CC-299681453A54Q35693550-13FAC544-EE13-4708-B1C4-7E418803B976Q35719328-03165B92-7698-4125-A5C6-5C9C27869A59Q35757502-BF27CFC1-0392-4793-9935-FD5650D934D1Q35887493-E17FD219-DFA2-4069-B90D-45C1DC85A83FQ36161556-85028D2F-5CCE-4413-ADAB-7FB5425B3D88Q36320919-15851909-A875-4584-92F7-E225A2A15EA2Q36377291-C2F2FD91-7540-4AFB-9AAF-22D279FE1D81Q36408152-88FEFEFF-CCC6-4566-B39C-ACB0EEB7FE1FQ36627486-7883A8FE-72CD-4D2F-B3E2-0749B00086ADQ36703832-D1B79C68-3F72-4BA6-9FF0-6E11AC579366Q36740173-9F78868E-E243-46DF-A023-7551B9E97007Q36740193-7FF760E5-F8BF-45E6-9E00-83660D5B7CBDQ37048000-4E3670B9-27D1-4AA3-81B0-8CDA07EC5DB9Q37119883-DC73A531-F682-48EF-9554-55C491E6F433Q37358468-53452AB1-10BA-420B-809D-998B77FBB4DB
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adenosine receptors and their ligands.
@ast
Adenosine receptors and their ligands.
@en
type
label
Adenosine receptors and their ligands.
@ast
Adenosine receptors and their ligands.
@en
prefLabel
Adenosine receptors and their ligands.
@ast
Adenosine receptors and their ligands.
@en
P356
P1476
Adenosine receptors and their ligands
@en
P2093
P2888
P304
P356
10.1007/S002100000315
P577
2000-11-01T00:00:00Z
P5875
P6179
1026140348